01/10/2017 - 11:55am

The Philadelphia Inquirer is reporting that Heritage Pharmaceuticals’s former CEO and chairman, Jeffrey Glazer, and former SVP commercial operations, Jason Malek, admitted in federal court that between April 2013 and December 2015, they worked together to manipulate prices of  Heritage’s generics of doxycycline hyclate and glyburide. The two face up to 10 years in prison each. After the two were indicted 20 states filed suit against six generics companies, including Heritage. (Philadelphia Inquirer)

01/10/2017 - 11:40am

The drug is indicated to treat and prevent influenza A and as a treatment for parkinsonism and drug-induced extrapyramidal reactions. 

01/06/2017 - 1:13pm
The drug is indicated to treat or prevent bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease. 
01/04/2017 - 1:22pm

Sandoz‘s generic will be available in 40-, 80- and 125-mg dosage strengths.

01/03/2017 - 12:54pm

Lupin in the last week of 2016 received tentative approval for its generics of Benicar tablets, Giazo tablets and Livalo tablets. 

01/03/2017 - 12:05pm

The Food and Drug Administration approved three generics from New Jersey-based specialty generics company Teligent on the last day of 2016, the company announced Tuesday.

01/03/2017 - 11:36am

The company on Thursday announced the launch of its generics of Concerta extended-release tablets, Zovia tablets and Cerebyx injection. 

12/21/2016 - 11:45am

Walgreens has expanded the availability of prescription-free naloxone to 33 states and the District of Columbia.

12/16/2016 - 12:46pm

Carrying a wholesale acquisition cost of $300 per injection, it will reach pharmacies in a week.